| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |